Sherertz R J, Falk R J, Huffman K A, Thomann C A, Mattern W D
Arch Intern Med. 1983 Jan;143(1):52-6.
During a 12-month period, the use of a subclavian vein Uldall catheter (UC) for hemodialysis or plasmapheresis in 27 patients was studied prospectively. Ten patients had ten UC site infections. Organisms associated with these infections included Staphylococcus epidermidis (five), Staphylococcus aureus (four), Proteus mirabilis (two), and Enterococcus (one). The four S aureus infections occurred 1, 2, 4, and 9 days after UC insertion, whereas the five S epidermidis infections occurred 6, 17, 17, 26, and 97 days after insertion. Five patients had associated bacteremias; in one of these patients, the bacteremia was the major cause of death. The incidence of UC site infection and bacteremia based was higher than the incidence of infection reported with any other type of vascular access for hemodialysis. Further studies are necessary to define whether the UC should be routinely employed for temporary vascular access.
在为期12个月的时间里,对27例患者使用锁骨下静脉Uldall导管(UC)进行血液透析或血浆置换进行了前瞻性研究。10例患者发生了10次UC部位感染。与这些感染相关的微生物包括表皮葡萄球菌(5例)、金黄色葡萄球菌(4例)、奇异变形杆菌(2例)和肠球菌(1例)。4例金黄色葡萄球菌感染分别发生在UC插入后1、2、4和9天,而5例表皮葡萄球菌感染分别发生在插入后6、17、17、26和97天。5例患者发生了相关菌血症;其中1例患者,菌血症是主要死因。基于UC部位感染和菌血症的发生率高于报道的任何其他类型血液透析血管通路的感染发生率。有必要进行进一步研究以确定UC是否应常规用于临时血管通路。